PremiumPre-EarningsHBIO Earnings Report this Week: Is It a Buy, Ahead of Earnings? Harvard Bioscience’s Bertrand Loy to Step Down Harvard Bioscience CFO Resignation and Interim Appointment PremiumCompany AnnouncementsHarvard Bioscience Reports 2024 Financial Results Harvard Bioscience Navigates Growth Amid Challenges Harvard Bioscience reports Q4 adjusted EPS 6c vs. 4c last year PremiumThe FlyHarvard Bioscience reports Q3 EPS (2c), consensus 3c Harvard Bioscience sees Q4 revenue $23M-$26M, consensus $28.5M Is HBIO a Buy, Before Earnings? 
